Competitive Technologies, Inc. (OTCQX: CTTC) Distributor of Calmare--a non-invasive and non-narcotic chronic pain management medical device with FDA 510K Marketing Allowance
TV News Report on Calmare (June 7, 2013)
Scrambler Therapy/Calmare is covered under certain health plans.
More insurance plans are adding coverage daily. Please call David Palmieri of Calmare Pain Relief Solutions at (800) 899-0574 for the most up to date list of insurance companies covering this treatment.
The following companies offer plans that cover the Calmare treatment. Most New York state no-fault insurance companies do cover this procedure.
Blue Cross Blue Shield
The Empire Plan
Esurance Insurance Company
21 Century Insurance
Auto One Insurance
State Farm Insurance
New York Central Mutual
State Insurance Fund
TV News Report Calmare technology and patient testimonial (2011) (http://www.ksl.com/?nid=148&sid=16580318).
Deseret News article: (http://www.deseretnews.com/article/705388446/Device-used-by-southern-Utah-doctor-is-helping-people-live-a-life-without-constant-pain.html) highlighted the success Dr. Robert Chalmers of Utah had in treatment of a teenager who had suffered from severe pain from a nerve disorder called reflex neurovascular dystrophy, or RND, for nearly two years.
CTTC in summary
Calmare Specific Treatment Indications for Chronic Pain Include –
- Calmare is a medical device that treats Chronic Pain Patients, FDA and CE approved
116 million people experience Chronic Pain in the US.
There are independently initiated clinical trials at the Mayo, University of Wisconsin, Massey Cancer Center and Johns Hopkins to validate the significant results that have been observed.
194 systems have been sold worldwide with 16 currently in place with the VA and US Navy Hospitals.
450 Calmare Units in inventory
·Chronic Neuropathic Pain
- Chemotherapy Induced Peripheral Neuropathy (CIPN)
Intractable Cancer Pain
Failed Back Surgery Syndrome
Sciatic and Lumbar Pain
Post Herpetic Neuralgia
Brachial Plexus Pain
Low Back Pain